LPM3480226

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LPM3480226, covering 2019-02-20 to 2019-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors [Phase 1]

See pricing